TAA
DNA icon

TB Alternative Assets’s Ginkgo Bioworks DNA Stock Holding History

TB Alternative Assets’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,625
Closed -$864K – 41
2024
Q1 		$864K Hold
18,625
– – 0.22% 35
2023
Q4 		$1.26M Buy
18,625
+10,592
+132% +$649K 0.34% 36
2023
Q3 		$582K Hold
8,033
– – 0.16% 38
2023
Q2 		$598K Hold
8,033
– – 0.15% 35
2023
Q1 		$427K Hold
8,033
– – 0.11% 38
2022
Q4 		$543K Hold
8,033
– – 0.2% 37
2022
Q3 		$1M Buy
+8,033
New +$957K 0.36% 37

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return